Status:
COMPLETED
Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
HIV
Tuberculosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Tuberculosis is a current infection during HIV infection. After infectious contact, some patients will develop tuberculosis some will only be infected without symptoms, they have Latent Tuberculosis I...
Detailed Description
Principal outcome: -Theoretic therapeutic impact evaluation of the use of IGRAS for diagnosis of LTBI in HIV-infected patients . Secondary outcomes: * Medico-economic impact of replacement of TST b...
Eligibility Criteria
Inclusion
- 18 yrs old Confirmed HIV infection No HAART Consent signed 6 months follow-up possible
Exclusion
- Confirmed TB disease No social right pregnancy
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
536 Patients enrolled
Trial Details
Trial ID
NCT00805272
Start Date
February 1 2009
End Date
February 1 2012
Last Update
March 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de médecine interne hôpital saint louis
Paris, Paris, France, 75018